Centre for NanoHealth

1
Centre for NanoHealth
Dr Matt Elwin Centre Manager Centre for
NanoHealth
2
Centre for NanoHealth
NHS
ILS
MNC
Centre for NanoHealth Swansea University
www.nanohealth.swansea.ac.uk
3
Centre for NanoHealth

• 22M open access facility based in Hospital
  Environment
• Access to Patients, Clinical Research Facility
• Provide commercial space for companies

4
Key drivers

• Diagnosing and treating diseases
• Enhancing early intervention
• Non-hospital environments
• Personalised Medicine
• Economic development

5
(No Transcript)
6
CNH development path

• Fully integrated work flow
• Access at any stage
• Commercial support from onset of engagement
• Translational application

7
CNH focus on applied research
8
CNH Facility

• Unique unified centre for development of health
  related technology and translation to clinical
  application
• Single-site, single-building, housing
  bio-engineering, bio-medical, and clinical
  expertise with patient access and business
  incubation space
• 1500m2 of state of the art facilities
• Nano-fabrication clean room with integrated
  bio-clean room
• Bio-marker discovery, molecular biology
  evaluation and safety
• Biological, Rheometrical and Nanoscale
  Characterisation
• Printing scale up
• 200m2 dedicated centre for commercialisation and
  third mission activity

9
Equipment Capabilities
CNH Stage 1 May-Dec 2009
CNH Stage 2 New Facility Fully Operational Mar
2011
Current Capabilities
All from stage 1 integrated into fully equipped
labs, plus In clean room additional e-beam with
in situ deposition nanoprobe,
coat/alignbackside alignment, wafer bonding,
CVD, ICP, PVD, RTP, tube furnace, AFM. Fully
equipped bioclean room. Characterisation AFM
with Nanoprobe SEM
ILS (in brief) Biomarker discovery, Toxicology
e-beam lithography, AFM, SNOM, TERS, raman,
confocal, rheology, NMR, bio printing coating,
high throughput cell imaging, nanotoxicology, bio
functionalisation
MNC (in brief) AFM, SPM, XPS nanowire growth,
micro fabrication, rheology, printing
10
Case study Integrated sampling / diagnostics /
drug delivery

• Microneedle blood sampling
• Flow through microchannels to expose biosensor
• Signal transfer to drug delivery system

• Biosensor fabrication (Photo Electron Beam
  Lithography technology)

• Antibody attachment

• Microneedle Microfulidics fabrication (MEMS
  technology)

• Sensor feedback into drug delivery system

11
Partnering opportunities

• Various funding routes available to assist
  business engagement
• Go Wales (Student Placement)
• Business Support (Student Placement)
• Academic Expertise for Business (A4B)
• CIRP, KTC, Feasibility Study
• Knowledge Transfer Partnerships (KTP)
• Employer Study Placement
• Case Studentships
• Technology Strategy Board (TSB)

12
NanoHealth

• Substantial opportunities - Sustainable benefits
• Driving forward the Knowledge Economy
• New High Value Global Sector
• Job creation
• Global exposure
• High return on Investment

13
Questions ?

• We are Open for Business Today

Dr Steve ConlanTel No 44 (0)1792 295386Email
r.s.conlan_at_swansea.ac.uk Email
nanohealth_at_swansea.ac.uk
Prof Steve WilksTel No 44 (0)1792
513041Email s.p.wilks_at_swansea.ac.uk Email
nanohealth_at_swansea.ac.uk
Dr Matt Elwin, Centre ManagerTel No 44 (0)1792
602983Email m.p.elwin_at_swansea.ac.uk Email
nanohealth_at_swansea.ac.uk